インタラクティブ・ペイシェント・ケア（IPC）市場とインタラクティブ・ペイシェント・エンゲージメント・ソリューション市場：製品（ハードウェア（テレビ、IBT/アシストデバイス、タブレット）、ソフトウェア）、タイプ（入院、外来）、エンドユーザー（病院、診療所）、地域別 - 2027年までの世界予測

Interactive Patient Care (IPC) Market and Interactive Patient Engagement Solutions Market by Product (Hardware (Television, IBT/ Assisted Devices, Tablets), Software), Type (Inpatient, Outpatient), End User (Hospitals, Clinics) and Region - Global Forecast to 2027

インタラクティブ患者エンゲージメントソリューション市場は、予測期間中に15.5%のCAGRで、2022年の1億4600万米ドルから2027年には3億米ドルに達すると予測されます。この市場の成長は、政府のイニシアチブの増加... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年7月20日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	179	58	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

インタラクティブ患者エンゲージメントソリューション市場は、予測期間中に15.5%のCAGRで、2022年の1億4600万米ドルから2027年には3億米ドルに達すると予測されます。この市場の成長は、政府のイニシアチブの増加、技術的に高度な製品の迅速な導入、デジタルヘルスケアソリューションに関する認知度の向上が要因となっています。
しかし、医療インフラへの投資要件が大きいため、予測期間中はこの市場の成長がある程度抑制されると予想されます。

"予測期間中、ハードウェア分野が最も高い成長率を示すと推定される"
製品別では、インタラクティブ患者エンゲージメントソリューション市場は、ハードウェアとソフトウェアに二分されます。ハードウェア分野は、2021年のインタラクティブ患者エンゲージメントソリューション市場で最大のシェアを占め、予測期間中に最も速いCAGRで成長すると予測されている。テレビベースのソリューションの開発の高まりと病院による室内テレビの採用が、この分野の成長の主要因である。

"2021年のインタラクティブ患者エンゲージメントソリューション市場では、入院患者向けソリューションセグメントが最大のシェアを占めた"

タイプ別に見ると、インタラクティブ患者エンゲージメントソリューション市場は、入院患者向けソリューションと外来患者向けソリューションに二分されます。入院患者ソリューションセグメントは、2021年の世界市場で最大のシェアを占めています。患者ケアの改善の必要性と、これらのソリューションの採用に対する政府の有利なイニシアチブは、このセグメントの市場成長を支える要因の一部です。

"エンドユーザーの病院部門は、2022年に世界のインタラクティブ患者エンゲージメントソリューション市場で最大のシェアを占めると予想される"
エンドユーザー別に見ると、インタラクティブ患者エンゲージメントソリューション市場は、病院、診療所、その他のエンドユーザーに二分されます。2021年のインタラクティブ患者エンゲージメントソリューション市場では、病院部門が最大の市場シェアを占めています。病院スタッフの需要に取り組むためのITツールに対する需要の高まりと、効果的なコミュニケーションツールに対する需要の高まりが、このセグメントの主な成長要因である。

"北米がインタラクティブ患者エンゲージメントソリューション市場を支配する2021年"

北米は、2021年にインタラクティブ患者エンゲージメントソリューション市場で最大かつ最も成長率の高い地域市場シェアを占め、予測期間中に最も高いCAGRで成長すると予測されています。政府の積極的な取り組み、慢性疾患の有病率の上昇、デジタルヘルスケア製品に関する認知度の向上が、このセグメントの市場成長を支える主な要因となっています。

供給側一次インタビューの内訳、企業タイプ別、呼称別、地域別。
- 企業タイプ別企業タイプ別：Tier 1 (25%)、Tier 2 (35%)、Tier 3 (40%)
- 役職別Cレベル(31%)、ディレクターレベル(36%)、その他(31%)
- 地域別北米 (55%)、ヨーロッパ (15%)、アジア太平洋 (25%)、その他の地域 (5%)

本市場における主なプレイヤーは、GetWellNetwork（米国）、Epic Systems Corporation（米国）、SONIFI Health（米国）、Barco（ベルギー）、Sentrics（米国）、Advantech Co, Ltd.（台湾）、Aceso Interactive Co.(台湾)、Aceso Interactive Inc.（米国）、HealthHub Patient Engagement Solutions（カナダ）、Lincor, Inc.（米国）、eVideon（米国）、Remedi Complete Medical Solutions（台湾）、i3solutions（カナダ）、PDi Communication Systems, Inc.（米国）、BEWATEC ConnectedCare GmbH（ドイツ）、Hôpitel Inc.（ドイツ）、Hospedia Inc.(カナダ）、Hospedia（イギリス）、Onyx Healthcare Inc.（アメリカ）、ClinicAll（アメリカ）、ARBOR Technology Corp.（台湾）、Healthcare Information, LLC（アメリカ）、Oneview Healthcare（アイルランド）、Siemens（ドイツ）、Vecoton（中国）、pCare（アメリカ）、および Medix-Care GmbH（ドイツ）である。これらのプレイヤーは、インタラクティブ患者エンゲージメントソリューション市場における製品提供を拡大するために、製品の発売、拡張、買収、パートナーシップにますます注力しています。

調査対象
- 本レポートでは、インタラクティブ患者エンゲージメントソリューション市場をタイプ、製品、エンドユーザー、地域に基づいて調査しています。
- 市場の成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。
- 利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争環境の詳細を提供します。
- マイクロ市場の成長動向、展望、および対話型患者エンゲージメントソリューション市場全体への貢献度に関して調査しています。
- レポートでは、4つの主要地域に関して市場セグメントの売上を予測しています。

レポート購入の主なメリット

本レポートは、市場全体とサブセグメントに関する収益数の最も近い近似値に関する情報を提供し、この市場のリーダー/新規参入者を支援します。本レポートは、利害関係者が競争環境を理解し、より良いビジネスの位置づけと適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、ステークホルダーが対話型患者エンゲージメントソリューション市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

ページTOPに戻る

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 INCLUSIONS AND EXCLUSIONS 27
1.3.1 MARKETS COVERED 27
FIGURE 1 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET SEGMENTATION 27
1.3.2 YEARS CONSIDERED 28
1.4 CURRENCY 28
1.5 LIMITATIONS 28
1.6 STAKEHOLDERS 29
1.7 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.2 RESEARCH METHODOLOGY STEPS 30
FIGURE 2 RESEARCH METHODOLOGY: INTERACTIVE PATIENT ENGAGEMENT
SOLUTIONS MARKET 30
FIGURE 3 RESEARCH DESIGN 31
2.2.1 SECONDARY DATA 31
2.2.1.1 Key data from secondary sources 32
2.2.2 PRIMARY RESEARCH 33
FIGURE 4 PRIMARY SOURCES 33
2.2.3 KEY INDUSTRY INSIGHTS 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.3 MARKET SIZE ESTIMATION METHODOLOGY 35
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 35
FIGURE 7 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 36
FIGURE 8 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 36
2.3.1 GROWTH FORECAST 36
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE INTERACTIVE PATIENT ENGAGEMENT MARKET (2022–2027) 37
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 38
FIGURE 11 DATA TRIANGULATION METHODOLOGY 38
2.5 STUDY ASSUMPTIONS 39
2.6 LIMITATIONS 39

3 EXECUTIVE SUMMARY 40
FIGURE 12 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 40
FIGURE 13 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 41
FIGURE 14 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 41
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET 42
4 PREMIUM INSIGHTS 43
4.1 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW 43
FIGURE 16 FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET 43
4.2 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE AND COUNTRY (2021) 44
FIGURE 17 INPATIENT SOLUTIONS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021 44
4.3 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY TYPE, 2022 VS. 2027 44
FIGURE 18 INPATIENT SOLUTIONS SEGMENT WILL CONTINUE TO DOMINATE INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2027 44
5 MARKET OVERVIEW 45
5.1 MARKET DYNAMICS 45
FIGURE 19 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
5.1.1 DRIVERS 46
5.1.1.1 Need for improved interactive patient engagement solutions 46
5.1.1.2 Growing number of collaborations and partnerships between stakeholders 46
5.1.1.3 Favorable government regulations and initiatives to promote adoption of HCIT solutions 47
5.1.2 RESTRAINTS 47
5.1.2.1 High infrastructural requirement and implementation costs 47
5.1.2.2 Data security concerns 47
FIGURE 20 TYPES OF HEALTHCARE BREACHES REPORTED TO THE US DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2018−2020 48
5.1.3 OPPORTUNITIES 48
5.1.3.1 Emerging countries offer high-growth potential 48
5.1.3.2 Technological advancements 49
5.1.4 CHALLENGES 49
5.1.4.1 Dearth of skilled professionals 49
5.2 CASE STUDIES 49
5.2.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE 49
TABLE 1 USE CASE 1: TO REDUCE PATIENT STAY 49
5.2.2 IMPROVE OUTPATIENT COMMUNICATION 50
TABLE 2 USE CASE 2: TO CURB COMMUNICATION ISSUES WITH DISCHARGED PATIENTS 50
5.2.3 INTERACTIVE PLATFORMS IMPROVE HOSPITAL OUTCOMES 50
TABLE 3 USE CASE 3: TO IMPROVE PATIENT EDUCATION COMPLETION RATES VIA IN-ROOM TELEVISIONS 50
5.3 ECOSYSTEM COVERAGE 51
FIGURE 21 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 51
5.4 TECHNOLOGY ANALYSIS 51
TABLE 4 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 51
5.5 REGULATIONS 52
5.5.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA) 52
5.5.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH) 52
5.5.3 CONSUMER PRIVACY PROTECTION ACT OF 2017 52
5.5.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015 52
5.5.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA 52
5.5.6 AFFORDABLE CARE ACT, 2010 53
5.5.7 GENERAL DATA PROTECTION REGULATION (GDPR) 53
5.5.8 CALIFORNIA CONSUMER PRIVACY ACT (CCPA) 53
5.6 PRICING ANALYSIS 53
5.7 MARKET SURVEY ANALYSIS: END-USER VIEWPOINT 54
FIGURE 22 FACTORS INFLUENCING THE ADOPTION OF INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS 55
5.8 PORTER’S FIVE FORCES ANALYSIS 55
TABLE 5 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS 55
5.9 INDUSTRY TRENDS 56
5.9.1 RISING NEED FOR INTEROPERABILITY AND INTEGRATION OF HCIT SOLUTIONS 56
5.9.2 GROWING DEMAND FOR VALUE-BASED HEALTHCARE 56
6 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE 58
6.1 INTRODUCTION 59
TABLE 6 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 59
6.2 INPATIENT SOLUTIONS 59
6.2.1 NEED FOR PATIENT INVOLVEMENT IN CARE PROCESS TO SUPPORT MARKET GROWTH 59
TABLE 7 INPATIENT INTERACTIVE ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 60
TABLE 8 NORTH AMERICA: INPATIENT INTERACTIVE ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 60
TABLE 9 EUROPE: INPATIENT INTERACTIVE ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 61
TABLE 10 ASIA PACIFIC: INPATIENT INTERACTIVE ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 61
6.3 OUTPATIENT SOLUTIONS 61
6.3.1 LARGE NUMBER OF OUTPATIENT PROCEDURES TO DRIVE MARKET 61
TABLE 11 OUTPATIENT INTERACTIVE ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 62
TABLE 12 NORTH AMERICA: OUTPATIENT INTERACTIVE ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 62
TABLE 13 EUROPE: OUTPATIENT INTERACTIVE ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 63
TABLE 14 ASIA PACIFIC: OUTPATIENT INTERACTIVE ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 63
7 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT 64
7.1 INTRODUCTION 65
TABLE 15 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 65
7.2 HARDWARE 65
TABLE 16 INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 66
TABLE 17 INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 66
TABLE 18 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 66
TABLE 19 EUROPE: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 67
TABLE 20 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 67
7.2.1 IN-ROOM TELEVISIONS 67
7.2.1.1 Increase in adoption of in-room televisions by hospitals 67
TABLE 21 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY REGION, 2020–2027 (USD MILLION) 68
TABLE 22 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2020–2027 (USD MILLION) 68
TABLE 23 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2020–2027 (USD MILLION) 69
TABLE 24 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2020–2027 (USD MILLION) 69
7.2.2 INTEGRATED BEDSIDE TERMINALS/ASSISTIVE DEVICES 70
7.2.2.1 Integrated bedside terminals enhance patient experience 70
TABLE 25 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTIVE DEVICES, BY REGION, 2020–2027 (USD MILLION) 70
TABLE 26 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTIVE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 70
TABLE 27 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTIVE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 71
TABLE 28 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTIVE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 71
7.2.3 TABLETS 72
7.2.3.1 Portability and cost-effectiveness of tablets supporting adoption 72
TABLE 29 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY REGION, 2020–2027 (USD MILLION) 72
TABLE 30 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2020–2027 (USD MILLION) 73
TABLE 31 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2020–2027 (USD MILLION) 73
TABLE 32 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2020–2027 (USD MILLION) 74
7.3 SOFTWARE 74
7.3.1 SOFTWARE HELPS PERFORM PRIMARY TASKS 74
TABLE 33 INTERACTIVE PATIENT ENGAGEMENT SOFTWARE SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 75
TABLE 34 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOFTWARE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 75
TABLE 35 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOFTWARE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
TABLE 36 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOFTWARE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
8 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 77
8.1 INTRODUCTION 78
TABLE 37 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 78
8.2 HOSPITALS 78
8.2.1 HOSPITALS LARGEST AND FASTEST-GROWING END USERS OF INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS 78
TABLE 38 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 79
TABLE 39 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 79
TABLE 40 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 80
TABLE 41 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 80
8.3 CLINICS 81
8.3.1 REDUCED MORTALITY RATES WITH USE OF INTERACTIVE BEDSIDE SOLUTIONS 81
TABLE 42 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLINICS, BY REGION, 2020–2027 (USD MILLION) 81
TABLE 43 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 81
TABLE 44 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 82
TABLE 45 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 82
8.4 OTHER END USERS 82
TABLE 46 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 83
TABLE 47 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 83
TABLE 48 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 84
TABLE 49 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 84
9 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION 85
9.1 INTRODUCTION 86
TABLE 50 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 86
9.2 NORTH AMERICA 87
FIGURE 23 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 87
TABLE 51 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 52 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 88
TABLE 53 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 54 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 55 NORTH AMERICA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 89
9.2.1 US 89
9.2.1.1 US dominates North American interactive patient engagement solutions market 89
TABLE 56 US: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 90
TABLE 57 US: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 58 US: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 59 US: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 91
9.2.2 CANADA 92
9.2.2.1 Government initiatives and awareness about digital healthcare solutions to support market growth 92
TABLE 60 CANADA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93
TABLE 61 CANADA: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 62 CANADA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 63 CANADA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 94
9.2.3 MEXICO 94
9.2.3.1 Growing COVID-19 cases and need to curtail healthcare costs supporting market growth 94
TABLE 64 MEXICO: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94
TABLE 65 MEXICO: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 66 MEXICO: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 67 MEXICO: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 95
9.3 EUROPE 96
TABLE 68 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 69 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 96
TABLE 70 EUROPE: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 71 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 72 EUROPE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 97
9.3.1 GERMANY 98
9.3.1.1 Germany largest market for interactive patient engagement solutions in Europe 98
TABLE 73 GERMANY: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 98
TABLE 74 GERMANY: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 75 GERMANY: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 76 GERMANY: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 99
9.3.2 UK 100
9.3.2.1 Initiatives to improve healthcare to boost market 100
TABLE 77 UK: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100
TABLE 78 UK: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 79 UK: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 80 UK: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 101
9.3.3 FRANCE 102
9.3.3.1 Rising geriatric population in France to support market growth 102
TABLE 81 FRANCE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102
TABLE 82 FRANCE: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 83 FRANCE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 84 FRANCE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 103
9.3.4 ITALY 103
9.3.4.1 Growing burden of chronic diseases driving market 103
TABLE 85 ITALY: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104
TABLE 86 ITALY: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 87 ITALY: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 88 ITALY: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 105
9.3.5 SPAIN 105
9.3.5.1 Technological innovations to support market growth 105
TABLE 89 SPAIN: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105
TABLE 90 SPAIN: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 106
TABLE 91 SPAIN: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 106
TABLE 92 SPAIN: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 106
9.3.6 REST OF EUROPE 107
TABLE 93 ROE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 107
TABLE 94 ROE: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 95 ROE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 96 ROE: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 108
9.4 ASIA PACIFIC 109
FIGURE 24 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 109
TABLE 97 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 98 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 110
TABLE 99 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 100 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 101 ASIA PACIFIC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 111
9.4.1 JAPAN 111
9.4.1.1 Fast adoption of advanced technologies and rising geriatric population key growth drivers 111
TABLE 102 JAPAN: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 112
TABLE 103 JAPAN: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 104 JAPAN: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 105 JAPAN: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 113
9.4.2 CHINA 113
9.4.2.1 Government initiatives to drive market in China 113
TABLE 106 CHINA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 113
TABLE 107 CHINA: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 108 CHINA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 109 CHINA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 114
9.4.3 INDIA 115
9.4.3.1 Rising healthcare awareness and changing demographics to drive market 115
TABLE 110 INDIA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 115
TABLE 111 INDIA: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 112 INDIA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 113 INDIA: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 116
9.4.4 REST OF ASIA PACIFIC 116
TABLE 114 ROAPAC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 117
TABLE 115 ROAPAC: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 116 ROAPAC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 117 ROAPAC: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 118

9.5 REST OF THE WORLD 118
TABLE 118 ROW: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 119 ROW: INTERACTIVE PATIENT ENGAGEMENT HARDWARE SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 120 ROW: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 121 ROW: INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 120
10 COMPETITIVE LANDSCAPE 121
10.1 OVERVIEW 121
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 121
TABLE 122 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET 121
10.3 MARKET RANKING 122
FIGURE 25 RANKING OF COMPANIES IN INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET (2021) 123
10.4 COMPETITIVE LEADERSHIP MAPPING 123
10.4.1 STARS 124
10.4.2 EMERGING LEADERS 124
10.4.3 PERVASIVE PLAYERS 124
10.4.4 PARTICIPANTS 124
FIGURE 26 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021) 125
10.5 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES 126
10.5.1 PROGRESSIVE COMPANIES 126
10.5.2 STARTING BLOCKS 126
10.5.3 RESPONSIVE COMPANIES 126
10.5.4 DYNAMIC COMPANIES 126
FIGURE 27 INTERACTIVE PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2021) 127
10.6 COMPANY FOOTPRINT 128
TABLE 123 FOOTPRINT OF COMPANIES 128
TABLE 124 PRODUCT FOOTPRINT OF COMPANIES 128
TABLE 125 REGIONAL FOOTPRINT OF COMPANIES 128
10.7 COMPETITIVE SCENARIO 129
TABLE 126 PRODUCT LAUNCHES, JANUARY 2018–JUNE 2022 129
TABLE 127 DEALS, JANUARY 2018–JUNE 2022 130
TABLE 128 OTHER DEVELOPMENTS, JANUARY 2018–JUNE 2022 133

11 COMPANY PROFILES 135
11.1 KEY PLAYERS 135
(Business Overview, Products & Services Offered, Recent Developments, and MnM View)*
11.1.1 GETWELLNETWORK, INC. 135
TABLE 129 GETWELLNETWORK, INC.: BUSINESS OVERVIEW 135
11.1.2 EPIC SYSTEMS CORPORATION 138
TABLE 130 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW 138
11.1.3 SONIFI HEALTH 140
TABLE 131 SONIFI HEALTH: BUSINESS OVERVIEW 140
11.1.4 ADVANTECH CO., LTD. 143
TABLE 132 ADVANTECH CO., LTD.: BUSINESS OVERVIEW 143
FIGURE 28 ADVANTECH CO., LTD.: COMPANY SNAPSHOT (2021) 143
11.1.5 BARCO 146
TABLE 133 BARCO: BUSINESS OVERVIEW 146
FIGURE 29 BARCO: COMPANY SNAPSHOT (2021) 147
11.1.6 SENTRICS 149
TABLE 134 SENTRICS: BUSINESS OVERVIEW 149
11.1.7 HOSPEDIA LIMITED 152
TABLE 135 HOSPEDIA LIMITED: BUSINESS OVERVIEW 152
11.1.8 EVIDEON 153
TABLE 136 EVIDEON: BUSINESS OVERVIEW 153
11.1.9 ACESO INTERACTIVE INC. 155
TABLE 137 ACESO INTERACTIVE INC.: BUSINESS OVERVIEW 155
11.1.10 PDI COMMUNICATION SYSTEMS, INC. 157
TABLE 138 PDI COMMUNICATION SYSTEMS, INC.: BUSINESS OVERVIEW 157
11.1.11 LINCOR, INC. 159
TABLE 139 LINCOR, INC.: BUSINESS OVERVIEW 159
11.1.12 CLINICALL 161
TABLE 140 CLINICALL: BUSINESS OVERVIEW 161
11.1.13 HÔPITEL INC. 162
TABLE 141 HÔPITEL INC.: BUSINESS OVERVIEW 162
11.1.14 I3SOLUTIONS INC. 164
TABLE 142 I3SOLUTIONS: BUSINESS OVERVIEW 164
11.1.15 HEALTHHUB PATIENT ENGAGEMENT SOLUTIONS 165
TABLE 143 HEALTHHUB PATIENT ENGAGEMENT SOLUTIONS: BUSINESS OVERVIEW 165
11.1.16 ARBOR TECHNOLOGY CORP. 167
TABLE 144 ARBOR TECHNOLOGY CORP.: BUSINESS OVERVIEW 167
11.1.17 HEALTHCARE INFORMATION, LLC 168
TABLE 145 HEALTHCARE INFORMATION, LLC: BUSINESS OVERVIEW 168
11.1.18 BEWATEC CONNECTEDCARE GMBH 170
TABLE 146 BEWATEC CONNECTEDCARE GMBH: BUSINESS OVERVIEW 170
11.1.19 ONYX HEALTHCARE INC. 172
TABLE 147 ONYX HEALTHCARE INC.: BUSINESS OVERVIEW 172
11.1.20 REMEDI COMPLETE MEDICAL SOLUTIONS 173
TABLE 148 REMEDI COMPLETE MEDICAL SOLUTIONS: BUSINESS OVERVIEW 173
*Business Overview, Products & Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2 OTHER KEY PLAYERS 175
11.2.1 ONEVIEW HEALTHCARE 175
11.2.2 SIEMENS 176
11.2.3 VECOTON 177
11.2.4 PCARE 177
11.2.5 MEDIX-CARE GMBH 178
12 APPENDIX 179
12.1 DISCUSSION GUIDE 179
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 182
12.3 CUSTOMIZATION OPTIONS 184
12.4 RELATED REPORTS 184
12.5 AUTHOR DETAILS 185

ページTOPに戻る

Table of Contents

Summary

The interactive patient engagement solutions market is projected to reach USD 300 million by 2027 from USD 146 million in 2022, at a CAGR of 15.5% during the forecast period. The growth of this market is driven by the increasing government initiatives, fast adoption of technologically advanced products, and increasing awareness about digital healthcare solutions.
However, large investment requirements for healthcare infrastructure are expected to restrain the growth of this market to a certain extent during the forecast period.

“Hardware segment is estimated to grow at the highest rate over the the forecast period”
On the basis of product, the interactive patient engagement solutions market is bifurcated into hardware and software. The hardware segment accounted for the largest share of the interactive patient engagement solutions market in 2021 and expected to grow fastest CAGR during the forecast period.Rising development of TV-based solutions and the increased adoption of in-room televisions by hospitals are the key factors for the growth of this segment.

“The inpatient solutions segment accounted for the largest share of the Interactive patient engagement solutions market in 2021”

On the basis of type, the interactive patient engagement solutions market is bifurcated into inpatient and outpatient solutions. The inpatient solutions segment accounted for the largest share of the global marketin 2021. The need for improved patient care and favorable government initiatives for the adoption of these solutions are some of the factors supporting the market growth of this segment.

“Hospitals segment in the end users is expected expectd to hold the largest share of the global Interactive patient engagement solutions market in 2022”
On the basis of end users, the interactive patient engagement solutions market is bifurcated into hospitals, clinics, and other end users. The hospitals segment accounted for the largest market share of the interactive patient engagement solutions market in 2021. Rising demand for IT tools to tackle the demand of hospital staff and the increasing demand for effective communication tools are the key growth factor of this segment.

“North America to dominate the Interactive patient engagement solutions marketin 2021”

North America accounted for the largest and the fastest-growing regional market share of the interactive patient engagement solutions market in 2021 and expected to grow at the highest CAGR during the forecasted period. Favorable government initiatives, the rising prevalence of chronic diseases, and rising awareness about digital healthcare products are the key factors supporting the market growth of this segment.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (25%), Tier 2 (35%), and Tier 3 (40%)
• By Designation: C-level (31%), Director-level (36%), and Others (31%)
• By Region: North America (55%), Europe (15%), Asia Pacific (25%), and Rest of the World (5%)

Prominent players in this market are GetWellNetwork (US), Epic Systems Corporation (US), SONIFI Health (US), Barco (Belgium), Sentrics (US), Advantech Co., Ltd. (Taiwan), Aceso Interactive Inc. (US), HealthHub Patient Engagement Solutions (Canada), Lincor, Inc. (US), eVideon (US), Remedi Complete Medical Solutions (Taiwan), i3solutions (Canada), PDi Communication Systems, Inc. (US), BEWATEC ConnectedCare GmbH (Germany), Hôpitel Inc. (Canada), Hospedia (UK), Onyx Healthcare Inc. (US), ClinicAll (US), ARBOR Technology Corp. (Taiwan), Healthcare Information, LLC (US), Oneview Healthcare (Ireland), Siemens (Germany), Vecoton (China), pCare (US), and Medix-Care GmbH (Germany). These players are increasingly focusing on product launches, expansions, acquisitions, and partnerships to expand their product offerings in the interactive patient engagement solutions market.

Research Coverage
• The report studies the interactive patient engagement solutions market based on type, product, end user, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total interactive patient engagement solutions market
• The report forecasts the revenue of market segments with respect to four major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the interactive patient engagement solutions market and provides them information on key market drivers, restraints, challenges, and opportunities.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（在宅・地域医療）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（hospitals）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（在宅・地域医療）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（hospitals）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?